RECRUITING

Incorporating Healthy Living Strategies to Aid in Recovery After Acute Pulmonary Embolism

Talk to us

Conditions

Acute Pulmonary EmbolismRecovery acute pulmonary embolismSix minute walkCardiac Effortactigraphy

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of the ERAsE-PE study is to determine whether two different healthy living strategies (along with anticoagulation) might aid in recovery after a patient is hospitalized for pulmonary embolism. Specifically, Investigators will compare changes in Cardiac Effort (#heart beats used during the 6-minute walk test/walk distance) measured after an 8-week program.

Official Title

Recovery After Acute Pulmonary Embolism

Quick Facts

Study Start:2025-02-27
Study Completion:2027-12-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06784492

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. English speaking (\>18 years old). Daily messages will be sent in English.
  2. 2. Acute PE with at least one of the following:
  3. 1. any right ventricular enlargement or dysfunction on echocardiogram;
  4. 2. CT Angiogram reporting any right ventricular enlargement; or
  5. 3. elevated cardiac biomarker (NT-pro BNP or troponin above baseline). Criteria for enrollment will be included on source document.
  6. 3. Rate controlled atrial arrythmias (resting heart rate \<110 beats/m) are eligible for enrollment. This includes atrial fibrillations. This is standard of care management for atrial fibrillation.
  7. 4. Subjects do need to take prescribed anticoagulation.
  1. 1. Pregnancy.
  2. 2. Cardiac Effort \>3.5 beats/m during 6MWT.
  3. 3. Resting tachycardia \>110 beats/m at hospital discharge.
  4. 4. Chronic Thromboembolic Pulmonary Hypertension
  5. 5. Systolic blood pressure \>180 mmHg at hospital discharge.
  6. 6. Inability to walk.
  7. 7. Estimated prognosis \<12 months at the time of discharge due to underlying co-morbidities (e.g., cancer).
  8. 8. Advanced neurologic disease and would not be able to comply with the messages.
  9. 9. Lack of access to email or text messaging 10. Inability or unwillingness to follow daily instructions.

Contacts and Locations

Study Contact

Daniel J Lachant, DO
CONTACT
5852769357
daniel_lachant@urmc.rochester.edu

Study Locations (Sites)

University of Rochester Medical Center
Rochester, New York, 14620
United States

Collaborators and Investigators

Sponsor: University of Rochester

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-02-27
Study Completion Date2027-12-01

Study Record Updates

Study Start Date2025-02-27
Study Completion Date2027-12-01

Terms related to this study

Keywords Provided by Researchers

  • Recovery acute pulmonary embolism
  • Six minute walk
  • Cardiac Effort
  • actigraphy

Additional Relevant MeSH Terms

  • Acute Pulmonary Embolism